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SUMMARY
Substrates are targeted for proteasomal degradation through the attachment of ubiquitin chains that 
need to be removed by proteasomal deubiquitinases prior to substrate processing. In budding 
yeast, the deubiquitinase Ubp6 trims ubiquitin chains and affects substrate processing by the 
proteasome, but the underlying mechanisms and its location within the holoenzyme remained 
elusive. Here we show that Ubp6 activity strongly responds to interactions with the base ATPase 
and the conformational state of the proteasome. Electron-microscopy analyses reveal that 
ubiquitin-bound Ubp6 contacts the N-ring and AAA+ ring of the ATPase hexamer, in close 
proximity to the deubiquitinase Rpn11. Ubiquitin-bound Ubp6 inhibits substrate deubiquitination 
by Rpn11, stabilizes the substrate-engaged conformation of the proteasome, and allosterically 
interferes with the engagement of a subsequent substrate. Ubp6 may thus act as an ubiquitin-
dependent timer to coordinate individual processing steps at the proteasome and modulate 
substrate degradation.
INTRODUCTION
Cell survival fundamentally depends on protein degradation, which in eukaryotes is carried 
out to a large extent by the ubiquitin-proteasome system (UPS)1,2. Cells not only must 
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maintain the proteome and degrade misfolded or damaged polypeptides, but degradation of 
regulatory and signaling proteins mediates numerous vital processes, ranging from 
transcription to cell division3. As the final destination in the ubiquitin-proteasome system, 
the essential 26S proteasome is a compartmental protease of the AAA+ family that 
mechanically unfolds and degrades protein substrates in an ATP-dependent manner. Most 
proteasomal substrates are marked for degradation and targeted to the proteasome by the 
enzymatic attachment of ubiquitin chains, which need to be removed by intrinsic 
deubiquitinases (DUBs) at the proteasome to allow efficient turnover4,5.
The S. cervesiae 26S proteasome consists of at least 34 different subunits that assemble into 
a 2.5 MDa complex. At the center of the holoenzyme is the barrel-shaped 20S core particle 
(CP) that sequesters the proteolytic active sites6. Access to the degradation chamber is 
controlled by the 19S regulatory particle (RP), which caps one or both ends of the 20S 
peptidase and can be further separated into the base and lid subcomplexes. The base contains 
three non-ATPase subunits, Rpn1, Rpn2 and Rpn13, as well as six distinct AAA+ ATPases 
(Rpt1-6) that form a heterohexameric ring with a central processing pore, constituting the 
unfoldase motor of the proteasome. ATP hydrolysis in the AAA+ domains of these ATPases 
is thought to drive conformational changes and propel movements of conserved pore loops 
to mechanically pull on substrate polypeptides and translocate them through the central 
channel into the peptidase7,89. In addition to the AAA+ domain, each Rpt subunit contains a 
N-terminal OB-fold domain that in the hexamer assembles into a distinct N-ring above the 
AAA+ domain ring. The lid subcomplex acts as a scaffold bound to one side of the base and 
contains the metalloprotease Rpn11, which is the essential deubiquitinase of the 
proteasome4,5. The base and lid subcomplexes must work together to recognize, process, 
and ultimately deliver substrates to the proteolytic core particle for cleavage into small 
peptides. Substrate proteins modified with ubiquitin chains of different linkage types, in 
particular K11 and K48, but in vitro also K63-linked chains10–12, are tethered to the 
proteasome by interacting with the intrinsic receptors Rpn10 and Rpn13 or transiently bound 
shuttle receptors13–17. Subsequently, the ATPase ring of the base engages an unstructured 
initiation region of the substrate and utilizes ATP hydrolysis to mechanically unfold and 
translocate the polypeptide. Concomitant with substrate translocation is the removal of 
ubiquitin modifications by the DUB Rpn11, which is localized above the entrance to the 
central pore of the base18,19.
Substrate degradation involves multiple conformational states of the proteasome regulatory 
particle. In the substrate-free state, the AAA+ domains of the Rpts adopt a steep spiral-
staircase arrangement that may facilitate substrate engagement20. Engagement induces the 
transition to the actively translocating state that is characterized by a more planar spiral 
staircase arrangement of the Rpts as well as a coaxial alignment of the N-ring and AAA+ 
ring with the peptidase, creating a continuous central channel for substrate translocation into 
the degradation chamber21,22. Furthermore, during this conformational change of the 
regulatory particle, Rpn11 shifts to a central position above the entrance to the pore where it 
is ideally placed to scan for and remove ubiquitins from substrates as they are translocated 
by the base ATPases. Thus, we surmise that for every substrate turnover, the proteasome 
transitions from a substrate-free, engagement-competent state to an engaged state that 
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facilitates processive translocation, unfolding, and deubiquitination. The proteasome has to 
switch back to the substrate-free conformation before the engagement of a subsequent 
substrate.
In addition to Rpn11, the 26S proteasome from S. cerevisiae contains another stably 
associated deubiquitinase, Ubp6, which shows high sequence and structural conservation 
with its human homologue, Usp1423. This 60 kDa ubiquitin specific protease (USP) uses an 
active site cysteine to cleave the isopeptide bonds within ubiquitin chains. Ubp6 is known to 
interact with Rpn1 of the base, but efforts to localize either Ubp6 or Usp14 in the context of 
the proteasome have failed24,25. Moreover, Ubp6 has been shown to catalytically and non-
catalytically affect the rates of proteasomal degradation. Ubp6 interferes with the critical 
substrate deubiquitination by Rpn11, stimulates 20S gate opening and thus increases access 
to the degradation chamber, and enhances the rates of ATP hydrolysis26–29. However, the 
mechanisms by which Ubp6 modulates the activities of the proteasome remain poorly 
understood.
Depletion of Ubp6 or Usp14 activity has dramatic consequences in vivo. Loss of Ubp6 
function, for example, increases aneuploidy tolerance in yeast, presumably due to an 
elevated proteasome capacity for turning over higher protein levels, and pharmacological 
inhibition of Usp14 in human cells has been shown to stimulate proteasome activity29–31. In 
the hippocampus, loss of Usp14 binding to the proteasome results in higher degradation 
rates that interfere with presynaptic formation, which can be rescued by overexpression of a 
catalytically inactive mutant32. Thus, both the catalytic and non-catalytic effects of Ubp6 on 
proteasome activity have important implications in cellular protein turnover. Understanding 
the interactions of Ubp6 with the proteasome in structural and mechanistic detail is therefore 
expected to provide important new insights into the role of this deubiquitinase in 
maintaining the proteome.
In this study we used biochemical and structural approaches on reconstituted proteasome 
complexes to investigate the nature of Ubp6 interaction. We found that the deubiquitination 
activity of Ubp6 depends on binding to the base ATPase and responds to the conformational 
state of the proteasome. By engineering a substrate recruitment system independent of 
polyubiquitin, we were able to separate catalytic and non-catalytic effects of Ubp6 on 
proteasomal activities. We localized Ubp6 by electron microscopy and show that it contacts 
both the N-ring and AAA+ ring of the base in its substrate-engaged conformation, 
positioning this deubiquitinase directly facing Rpn11. The position of Ubp6 is consistent 
with our biochemical findings that the ubiquitin-bound deubiquitinase strongly inhibits 
Rpn11 deubiquitination activity, stabilizes the translocating conformation of the 
holoenzyme, and prevents engagement of subsequent substrates.
RESULTS
Ubp6 activity responds to proteasome conformational states
The deubiquitination activity of Ubp6 has been shown to dramatically increase upon binding 
to the 26S proteasome24,26,29. To assess the mechanisms of this activation, we measured 
Ubp6 deubiquitination in the presence of purified proteasome subcomplexes20 and 4-amino-
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methyl-coumarin-fused ubiquitin (Ub-AMC), a substrate that increases fluorescence upon 
cleavage (Fig. 1). Despite its known interaction with Ubp6, Rpn1 alone failed to stimulate 
Ubp6 activity, whereas purified base or holoenzyme induced a 300-fold increase in 
deubiquitination. Thus, full activation of Ubp6 requires contacts with other base subunits in 
addition to Rpn1 (Fig. 1a).
Interestingly, Ubp6 deubiquitination activity also responds to the conformational state of the 
proteasome. ATPγS was previously shown to invoke a conformation that is similar to the 
substrate-engaged state21,22 (Supplementary Fig. 1). We therefore reconstituted the 
proteasome in the presence of ATPγS, and observed a 1.9-fold increase in Ubp6 
deubiquitination activity compared to the ATP-bound, substrate-free state of the proteasome 
(Fig. 1a). Importantly, this Ubp6 stimulation was also found for endogenous 26S 
holoenzyme purified from yeast, suggesting that the deubiquitinase indeed responds to an 
ATPγS-induced conformational change and not an alternative assembly state during in-vitro 
reconstitution (Fig. 1b). Proteasomes lacking Ubp6 or containing Ubp6 with a mutated 
active-site cysteine (C118A) did not show this ATPγS-dependent stimulation of 
deubiquitination, whereas the effect was still observed for proteasomes with the catalytically 
inactive Rpn11 AXA mutant4 (Fig. 1b). These results indicate that Ubp6, not Rpn11, is 
responsible for the stimulated deubiquitination activity in response to the engaged state of 
the proteasome.
Ubp6 allostery is connected to substrate engagement
Previous studies had shown that polyubiquitin-bound Ubp6 stimulates the ATPase rate of 
the proteasome28. This observation, together with our findings that ATP- and ATPγS-bound 
proteasomes differentially stimulate the deubiquitination activity of Ubp6, suggest that Ubp6 
may play a role in the conformational dynamics of the holoenzyme. The function of Ubp6 in 
ubiquitin processing during substrate degradation, however, complicates a detailed analysis 
of such potential allosteric effects. To deliver substrates to the proteasome in an ubiquitin-
independent manner, we therefore developed an artificial recruitment system by fusing a 
permuted single-chain variant of the dimeric substrate adapter SspB2 to the N-terminus of 
the ATPase subunit Rpt2 (Fig. 2a). In bacteria, SspB2 recruits substrates to the AAA+ 
protease ClpXP by recognizing a portion of the 11 amino acid ssrA tag33. Including this 
ssrA tag in our model substrates enables their ubiquitin-independent targeting to SspB2-
fused reconstituted proteasomes (Fig 2b), which are also still capable of degrading 
ubiquitinated substrates (Supplementary Fig. 2a). The SspB2-fused proteasomes allowed us 
to compare how ubiquitin binding to Upb6 and substrate engagement by the AAA+ ring 
stimulate ATP hydrolysis, and assess whether these processes affect the same or distinct 
conformations of the proteasome.
To enforce an ubiquitin-bound state of Ubp6, we used the catalytically inactive C118A 
mutant and incubated it with purified lysine-48 linked ubiquitin dimers34. Ubp6 C118A led 
to a 1.8-fold increase of proteasome ATPase activity only in the presence but not in the 
absence of di-ubiquitin (Fig. 2c), with comparable effects also observed for ATPase 
stimulation of the isolated base subcomplex (Supplementary Fig. 2b). The ATPase response 
of SspB2-fused proteasomes to ubiquitin-bound Ubp6 C118A strongly resembled the 
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behavior of wild-type proteasomes (Supplementary Fig. 2c), confirming that the SspB2-
fusion construct is well suited to separate ubiquitin-related processes from other aspects of 
substrate degradation. In addition, we covalently modified wild-type Ubp6’s active-site 
cysteine with ubiquitin vinyl-sulfone35. The resulting Ubp6-UbVS stimulated the 
proteasome ATPase activity similar to Ubp6 C118A in the presence of ubiquitin dimers 
(Fig. 2c), confirming that it is indeed the ubiquitin-bound state of Ubp6 that is responsible 
for the observed ATPase stimulation.
To analyze the substrate-induced stimulation of ATP hydrolysis, we used the SspB2-fused 
proteasomes in combination with an ssrA-tagged, permanently unfolded model protein that 
can get engaged and rapidly translocated without the extra burden of protein unfolding. 
Processing of this substrate caused a 3.3-fold increase in the ATPase rate of reconstituted 
proteasomes (Fig. 2c). Importantly, the addition of Ubp6 C118A and di-ubiquitin did not 
lead to a further increase, suggesting that substrate and ubiquitin-bound Ubp6 stimulate ATP 
hydrolysis by inducing or stabilizing a similar proteasome state, albeit to a different extent. 
Our previous structural comparison between substrate-free and substrate-engaged 
proteasomes suggest that the ATPase stimulation upon substrate engagement is caused by a 
switching of the AAA+ ring from a steep spiral staircase to a more planar conformation with 
uniform Rpt-subunit interfaces21. Ubiquitin-bound Ubp6 may thus also partially induce or 
stabilize this engaged conformation of the Rpt ring, which would be consistent with the 
observed reciprocal stimulation of Ubp6 deubiquitination activity by ATPγS-bound 
proteasomes.
In support of this hypothesis, we found that substrate engagement and translocation also 
stimulates Ubp6 deubiquitination activity, albeit not as strongly as trapping the base in a 
permanently engaged state with ATPγS (Supplementary Fig. 2d). Unfortunately, the 
ATPγS-bound state prevents substrate engagement and therefore made it impossible to 
assess whether the ATPase stimulation caused by substrate engagement and ATPγS binding 
are indeed non-additive, as expected based on the strong similarities between the 
corresponding proteasome structures21,22.
In summary, our data suggest that ubiquitin binding to Ubp6 and substrate engagement by 
the base result in the same proteasome state, marked by an increased ATPase rate and higher 
Ubp6 deubiquitination activity.
Ubp6 binds to the Rpt hexamer of the base
Previous biochemical studies reported that Ubp6 is tethered to the proteasome through 
interactions of its N-terminal Ubl domain with the Rpn1 subunit of the base, yet attempts to 
visualize and localize Ubp6 bound to the proteasome have been unsuccessful18,19. The Ubl 
and the catalytic USP domains of Ubp6 are connected by a flexible 23 amino-acid linker23, 
which may allow the deubiquitinase to sample a larger space around the regulatory particle 
for removal of ubiquitin chains docked on ubiquitin receptors Rpn10 or Rpn13. In addition 
to this mobile domain architecture of Ubp6, the high intrinsic flexibility of Rpn1, as 
indicated by consistently lower local resolutions in EM reconstructions18,19, likely 
hampered the localization and visualization of proteasome-bound Ubp6.
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Given the observed functional crosstalk between ubiquitin-bound Ubp6 and the base 
ATPase, we concluded that trapping Ubp6 in an ubiquitin-bound state might stabilize it on 
the proteasome for our EM structural studies. We therefore covalently modified Ubp6’s 
active-site cysteine with ubiquitin vinyl-sulfone35 and incubated the resulting Ubp6-UbVS 
with proteasomes in the presence of either ATP or ATPγS. ATP-bound proteasomes with 
Ubp6-UbVS exhibited a large degree of conformational heterogeneity (Supplementary Fig. 
3), which was clearly observed in the 3D classification of the dataset. Although we could 
distinguish multiple 3D structures representing a continuum of different conformational 
states of the regulatory particle (Supplementary Fig. 3), none of these reconstructed 
proteasomes in the presence of ATP contained sufficient particles to accurately localize the 
Ubp6 density. A 3D refinement of the combined dataset shows the holoenzyme in the apo 
conformation with diminished density in certain areas of the lid and especially the base, 
likely indicating the presence of proteasome particles in the engaged or hybrid states 
(Supplementary Fig. 4). Previous reconstructions of the proteasome with ubiquitin-free 
Ubp6 did not show such heterogeneity, suggesting that ubiquitin-bound Ubp6 may partially 
induce alternate conformations. This would be consistent with its stimulation of base ATP 
hydrolysis. Importantly, we also detected additional weak density next to Rpn1 that contacts 
the ATPase hexamer and may correspond to a mobile Ubp6-UbVS.
In contrast to the ATP-bound complex, proteasomes incubated with ATPγS and Ubp6-
UbVS exhibited less conformational heterogeneity and complete absence of the apo 
conformation, enabling 3D reconstructions of the holoenzyme in the engaged state (Fig. 3, 
Supplementary Fig. 5). This reconstruction shows an extra, defined density of appropriate 
size to accommodate the catalytic domain of Ubp6 or human Usp14 (Fig. 3a). Usp14 and 
Ubp6 share high structural conservation23, and we therefore generated a homology model of 
ubiquitin-bound Ubp6 based on the crystal structure of Usp14-ubiquitin aldehyde (PDB 
2AYO23), which was then docked into the additional electron density of the ATPγS-bound 
proteasome complex. Strikingly, the ubiquitin-bound Ubp6 binds directly to the ATPase 
hexamer of the base, primarily interacting with Rpt1 (Fig. 3a, e). In the docked model, the 
N-terminus of the ubiquitin-bound catalytic domain is positioned close to the density 
observed between Ubp6 and Rpn1 (Supplementary Fig. 6), which likely originates from the 
linker connecting the catalytic domain with the Ubl domain. Ubiquitin-bound Ubp6 contacts 
both the N-Ring and the AAA+ ring, which in the engaged, translocation-competent state of 
the base are coaxially aligned with the core particle. Ubp6’s position at the periphery of the 
N-ring places it directly in front of Rpn11, separated by ~30 Å. Especially in its ubiquitin-
bound state, Ubp6 may thus sterically occlude Rpn11’s access to ubiquitinated substrates, 
which could explain its previously reported inhibitory effects on Rpn11 DUB activity26. 
Interestingly, this location of the Ubp6 density and its presence in the engaged conformation 
of the proteasome agree with a previously unspecified density in substrate-processing 
proteasomes observed by EM tomography of neurons36.
Ubp6 affects proteasomal conformational dynamics
Given the specific interaction of ubiquitin-bound Ubp6 with the ATPase ring in its engaged, 
translocation-competent conformation, we wanted to characterize Ubp6's effects on 
substrate degradation independent of ubiquitin processing. We therefore measured the 
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ubiquitin-independent, SspB2-mediated degradation of a permanently unfolded model 
substrate as well as a folded GFP model substrate in the presence or absence of Ubp6 (Fig. 
4a). In contrast to the previously reported inhibition of ubiquitin-dependent substrate 
degradation26, ubiquitin-free Ubp6 C118A had minimal effect on ubiquitin-independent 
degradation. However, Ubp6 C118A bound to di-ubiquitin inhibited substrate turnover. This 
inhibition was observed for degradation of both the folded and unfolded substrates, 
indicating that ubiquitin-bound Ubp6 does not affect the protein-unfolding abilities of the 
proteasome. In its ubiquitin-bound state, Ubp6 thus increases the ATPase rate of the base 
but slows substrate degradation.
One possible explanation for these observations is that Ubp6 stabilizes the engaged, 
translocation-competent state of the proteasome and inhibits the reversion back to the apo 
conformation capable of engaging a new substrate. To test this hypothesis we analyzed 
degradation of the GFP substrate by SspB2-fused proteasomes in the presence of ubiquitin-
free or ubiquitin-bound Ubp6 under single-turnover conditions (excess enzyme over 
substrate), where measured fluorescence signals follow a single-exponential decay (Fig. 4b). 
Indeed, we observed no effect on single-turnover degradation, consistent with a scenario in 
which ubiquitin-bound Ubp6 might stabilize, but not strongly induce the substrate-engaged 
state, allowing efficient engagement of the first substrate. In contrast, multiple-turnover 
degradation was strongly inhibited by ubiquitin-bound Ubp6 (Fig. 4c). For degradation in 
the presence of only di-ubiquitin or ubiquitin-free Ubp6, the single-turnover rate constants 
agree well with the kcat values of multiple turnover. These data thus suggest a model where 
substrate engagement with the AAA+ ring induces the engaged conformation, which is then 
stabilized by ubiquitin-bound Ubp6, preventing the return to the apo, engagement-competent 
conformation until ubiquitin dissociates.
Ubp6 inhibition of ubiquitin-dependent degradation
Most substrates are targeted to the proteasome by attached polyubiquitin chains, which have 
to be removed by Rpn11 to allow efficient degradation4,5. We were thus interested in 
whether the close proximity of ubiquitin-bound Ubp6 to Rpn11 inhibited Rpn11-mediated 
deubiquitination and therefore ubiquitin-dependent substrate degradation. We directly 
analyzed the deubiquitination activity of Rpn11 by measuring Ub-AMC cleavage of 
holoenzymes with no Ubp6, Ubp6 C118A, ubiquitin-aldehyde (UbH)-modified wild-type 
Ubp6 or UbH-modified Ubp6 lacking its N-terminal Ubl domain (Fig. 5a). This 
deubiquitination activity was shown to be highly sensitive to the metal chelator o-
phenanthroline, confirming that it originated from Rpn11 (Supplementary Fig 2e). Covalent 
modification of Ubp6 with UbH ensured an ubiquitin-bound state without adding free di-
ubiquitin that would compete in the Rpn11 Ub-AMC cleavage assay. Ubp6-UbH inhibited 
Rpn11 by 85 %, whereas catalytically inactive Ubp6 C118A showed only 45 % inhibition. 
Ubp6-ΔUbl did not affect Rpn11 activity, indicating that the functional interaction with 
Rpn11 and presumably also binding to the Rpt ring itself depend on the Ubl-mediated 
tethering of Ubp6 to Rpn1.
As a model substrate for the degradation experiments we used a lysine-less variant of 
superfolder GFP37 fused to an unstructured region that contained a single lysine for in vitro 
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ubiquitination, thus reducing potential substrate heterogeneity due to multiple chain 
placements. To ensure a permanently ubiquitin-bound state of Ubp6, we modified its active 
site with ubiquitin-vinyl sulfone (Ubp6-UbVS). Importantly, Ubp6-UbVS behaves similarly 
to di-ubiquitin-bound Ubp6 based on the stimulation of proteasomal ATP hydrolysis 
(Supplementary Fig. 2c). Substrate degradation was measured under single- and multiple-
turnover condition using proteasomes purified from an ubp6Δ yeast strain with added-back 
wild-type Ubp6, Ubp6 C118A, or Ubp6-UbVS (Fig.5 b,c). It is worth noting that in contrast 
to ubiquitin-independent degradation, all ubiquitin-dependent single-turnover traces 
followed a double exponential decay, which is consistent with our previously published 
data20. We attribute this behavior to potential heterogeneity in the ubiquitin modification of 
individual substrate molecules, with shorter ubiquitin chains affecting proteasome binding 
and processing kinetics. In agreement with earlier reports26,29, we observed ~ 37 % slower 
multiple-turnover degradation in the presence of wild-type Ubp6 and a 48 % reduction in 
rate when the catalytically dead C118A mutant was bound to the proteasome (Fig. 5c). 
Similar to the results for ubiquitin-independent degradation, there were no substantial 
defects in single turnover, consistent with our model that, upon ubiquitin binding, Ubp6 may 
stabilize the engaged proteasome conformation, prevent switching back to the substrate-free 
conformation, and inhibit engagement of a subsequent substrate for multiple turnover. 
Proteasomes in complex with Ubp6-UbVS exhibited almost no detectable degradation in 
both multiple and single turnover (Fig. 5b,c).
Finally, gel-based analyses of the processing of an established poly-ubiquitinated GFP 
substrate18,20 revealed that Ubp6-UbVS bound proteasomes do show neither substantial 
degradation nor deubiquitination (Fig. 5d). This behavior suggests a model in which 
permanently ubiquitin-bound Ubp6 binds to the ATPase ring right after the substrate has 
entered the pore and induced the engaged conformation. The position of ubiquitin-bound 
Ubp6 in proximity to Rpn11 may sterically prevent Rpn11 access to the ubiquitin-modified 
lysine of our model substrate. Since the proteasome encounters this modified lysine before 
the GFP moiety, inhibiting ubiquitin-chain removal by Rpn11 would stall translocation and 
thus prohibit GFP unfolding. However, other substrates may behave differently depending 
on the substrate geometry and the position of ubiquitin modifications relative to the 
degradation initiation site. Despite a 45% inhibition of Rpn11 activity by Ubp6 C118A, we 
did not observe defects in single-turnover substrate degradation for this Ubp6 variant. It is 
possible that the catalytically inactive Ubp6 C118A is not ubiquitin-bound during 
degradation of the first substrate, but holds on to ubiquitin after Rpn11 cleavage, affecting 
Rpn11 deubiquitination and stabilizing the engaged state in multiple turnover. Alternatively, 
the on- and off-rates for uncleaved ubiquitin on Ubp6 C118A may still allow ubiquitin-chain 
binding and cleavage by Rpn11, but inhibit the base switching back to the pre-engaged state 
for multiple turnover. As a control, we verified that the proteasome did not engage and 
degrade any of the Ubp6 variants, which would also inhibit degradation of our model 
substrate (Supplementary Fig. 7).
DISCUSSION
Our biochemical and structural data show that, besides its role in ubiquitin cleavage, Ubp6 
affects proteasomal substrate degradation by allosterically interfering with distinct 
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proteasome functions in an ubiquitin-dependent manner. Prior to substrate engagement by 
the base, Ubp6 is tethered via its Ubl domain to Rpn1, while its catalytic USP domain 
appears to be rather mobile and sampling a larger area. Interactions of the USP domain with 
the base ATPase stimulate its deubiquitination activity, likely by changing the conformation 
of two blocking surface loops, BL1 and BL223, and this activity further increases upon 
proteasome engagement of a substrate polypeptide. Ubiquitin-bound Ubp6 binds and 
stabilizes this substrate-engaged, translocation-competent conformation of the proteasome 
by interacting with both the N-ring and the AAA+ ring of the base, thereby maintaining their 
coaxial alignment with the 20S core. The interaction with the base places ubiquitin-bound 
Ubp6 in close proximity to Rpn11, where it interferes with Rpn11-mediated substrate 
deubiquitination. These findings are also consistent with a recent EM-structural study38.
Our results suggest a model in which substrate engagement acts as a switch to induce the 
translocation-competent state of the proteasome, which is then regulated by ubiquitin-bound 
Ubp6 in two ways: the inhibition of Rpn11 and the interference with conformational 
switching back to the substrate-free state (Fig. 6). Ubp6 would inhibit Rpn11 
deubiquitination and therefore slow substrate degradation if it interacts with ubiquitin before 
Rpn11 has removed all modifications from a translocating substrate. Such coordination 
between Ubp6 and Rpn11 activities may be important for complex substrates containing 
multiple, very long, or branched polyubiquitin chains that need to be co-translocationally 
trimmed by Ubp6. After Rpn11 has cleaved off all ubiquitin modifications and a substrate 
has been completely unfolded and translocated, Ubp6 may trap the engaged conformation of 
the proteasome and prevent the engagement of a subsequent substrate until it is no longer 
occupied with ubiquitin. This mechanism would be important for Ubp6-mediated clearance 
of polyubiquitin chains from the several ubiquitin receptors before the proteasome commits 
to the degradation of a new substrate, and it would agree with Ubp6’s role in maintaining 
high levels of free ubiquitin in the cell39,40.
In our studies we either saturated ubiquitin-binding to catalytically dead Ubp6 or used 
covalent ubiquitin fusions to exaggerate the effects on proteasomal functions. However, 
given the fast kinetics of ubiquitin cleavage by Ubp6 compared to Rpn11, wild-type Ubp6 
that is processing ubiquitin modifications would not be expected to severely slow 
proteasomal substrate degradation. Ubp6 may rather act as a timer, not only as previously 
suggested by trimming of ubiquitin chains and thus affecting the persistence time of 
substrates at the proteasome, but in an ubiquitin-dependent manner by allosterically 
coordinating the various substrate-processing steps at the proteasome and preventing stalling 
of substrates with complex ubiquitin modifications.
Our EM structural work provides the first visualization of ubiquitin-bound Ubp6 in the 
context of the 26S proteasome. Future higher-resolution structures will be required to 
elucidate the detailed mechanisms involved in the reciprocal stimulation of Ubp6 
deubiquitination and base ATPase activities. It will also be interesting to investigate how 
Ubp6 coordinates with other proteasome-bound cofactors, for instance the ubiquitin ligase 
Hul524,41,42 or ubiquitin shuttle receptors Rad23, Ddi1, and Dsk215,25,43,44, in fine-tuning 
substrate processing by the 26S proteasome.
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METHODS
Yeast strains
Yeast lid and holoenzyme were purified from strain YYS40 (genotype MATa ade2-1 
his3-11,15 leu2-3,112 trp1-1 ura3-1 can1 Rpn11::Rpn11-3× Flag(His3)48. Core particle was 
prepared from either strain RJD1144 (genotype MATa his3Δ200 leu2-3,112 lys2-801 trpΔ63 
ura3-52 PRE1-Flag-His6::Ylpac211(URA3)49 or strain yAM14 (genotype MATa ade2-1 
his3-11,15 leu2-3,112 trp1-1 ura3-1 can1-100 bar1 PRE1::PRE1-3× Flag(KanMX),20). To 
generate UBP6 deletion strains, the kanMX6 sequence was integrated at the respective 
genomic locus, replacing the gene in YYS4018. To generate the UBP6 C118A strain, a 
C118A copy of Ubp6 was cloned into pRS305 and was integrated into the UBP6 deletion 
strain at the leu2 locus.
Purification of yeast holoenzyme and subcomplexes
Wild-type and mutant proteasome was purified from S. cerevisiae essentially as 
described.18,21 In summary, holoenzyme, lid, and core particle were purified from yeast 
strains listed above. Lysed cells were resuspended in lysis buffer containing 60 mM HEPES, 
pH 7.6, 50 mM NaCl, 50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 10% glycerol, and 0.2% 
NP-40. Holoenzyme lysis also included an ATP-regeneration mix (5 mM ATP, 0.03 mg/ml 
creatine kinase and 16 mM creatine phosphate). Complexes were bound to anti-Flag M2 
affinity resin (Sigma) and washed with wash buffer (60 mM HEPES, pH 7.6, 50 mM NaCl, 
50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 10% glycerol, 0.1% NP-40 and 500 mM ATP). 
Core particle was washed with wash buffer containing 500 mM NaCl, and Lid was washed 
with wash buffer containing 1M NaCl. Complexes were eluted with Flag peptide and 
separation by size-exclusion chromatography over Superose-6 in gel-filtration (GF) buffer 
(60 mM HEPES, pH 7.6, 50 mM NaCl, 50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA and 0.5 
mM ATP) containing 5% glycerol.
Recombinant expression and purification of proteins and complexes
Base subcomplexes were expressed and purified from E. col as previously described.20 Nine 
integral subunits (Rpn1, Rpn2, Rpn13, Rpts-1-6,) and four assembly chaperones (Rpn14, 
Hsm3, Nas2 and Nas6) were expressed with rare tRNAs at overnight at 18 °C after 
induction with 0.5 mM IPTG. Cells were harvested by centrifugation and resuspended in 
nickel buffer (60 mM HEPES, pH 7.6, 100 mM NaCl, 100 mM KCl, 10% glycerol, 10 mM 
MgCl2, 0.5 mM EDTA, and 20 mM imidazole) supplemented with 2 mg ml−1 lysozyme, 
protease inhibitors, (aprotinin, pepstatin, leupeptin and PMSF) and benzonase (Novagen). 
Cells were lysed with by freeze-thaw cycles and sonication, and clarified by centrifugation. 
A two-step affinity purification of the base subcomplex was performed using nickel–
nitrilotriacetic acid (Ni-NTA) agarose (Qiagen) to select for His6-Rpt3 and anti-Flag M2 
resin (Sigma-Aldrich) selecting for Flag-Rpt1. 0.5 mM ATP was present in all purification 
buffers. The Ni-NTA and anti-Flag M2 columns were eluted with nickel buffer containing 
250 mM imidazole and 0.15 mg ml−1 3× Flag peptide, respectively. The Flag column eluate 
was concentrated and run on a Superose 6 size exclusion column (GE Healthcare) 
equilibrated with gel filtration buffer (60 mM HEPES, pH 7.6, 50 mM NaCl, 50 mM KCl, 
10% glycerol, 5 mM MgCl2, 0.5 mM EDTA, 1 mM DTT and 0.5 mM ATP).
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The GFP fusion substrate construct was cloned into a pET Duet (Novagen) vector, and 
consisted of a lysinesless superfolder GFP37, lysineless titin I27 V15P domain, and a 
random coil containing the ssrA sequence and the PPXY motif. E. coli Bl21-star (DE3) cells 
were transformed with the construct and grown in Terrific Broth (EMD Millipore) at 30 °C. 
Cells were induced with 0.5 mM IPTG at an OD600 of 1–1.5 and expression went for 5 
hours at 30 °C.
The unfolded substrate was cloned into a pET 28A (Novagen) vector and consisted of a 
lysineless, disulfide-less N1 domain from gene-3-protein50 fused to a random coil 
containing an ssrA tag, ppxy motif, and a lysineless strepII tag. WT Ubp6 was amplified 
from genomic (W303) DNA, and cloned into pET Duet with an N-terminal His6 tag. C118A 
mutation was made by around-the-horn PCR. E. coli Bl21-star (DE3) cells were transformed 
with either the N1 construct or the Ubp6 constructs and grown in Terrific Broth at 37 °C. 
Cells were induced with 0.5mM IPTG at an OD600 of 0.6 and expression continued 
overnight at 18 °C.
GFP, unfolded substrate, or Ubp6 expressing cells were harvested by centrifugation and 
resuspended in nickel buffer (above) supplemented with 2 mg ml−1 lysozyme, benzonase 
(Novagen), and protease inhibitors (aprotinin, pepstatin, leupeptin and PMSF). Cells were 
lysed by freeze thaw and sonication. Lyates were clarified by centrifugation at 15,000 rpm 
for 20 minutes at 4 °C. Proteins were purified using Ni-NTA affinity chromatography 
followed by size exclusion chromatography on a Superdex 200 (GE Healthcare) using nickel 
and gel filtration buffers mentioned above.
Construction of the SspB2permutant base
To allow ubiquitin-independent substrate delivery to the proteasome, we created a base 
variant that is fused to a linked permutant dimer of the E.coli substrate adaptor SspB. A 
wild-type SspB monomer consists of a globular domain and a C-terminal tail of 38 residues. 
In simple dimer fusions, where we connected the C-terminus of the globular domain of one 
SspB monomer with the N-terminus of the second SspB monomer, the linker interfered with 
ssrA substrate binding to SspB2. We therefore constructed a circular permutant SspB 
monomer, in which we created a new N-terminus at residue L26 and connected the 
preceding N-terminal helix to the C-terminus of the globular domain, and fused this 
monomer to the N-terminus of a second, wild-type SspB monomer. The connectivity of this 
covalently fused dimer is: (L26-D111) - GGASG - (S4-Q25) - GGGTGG - (wild-type 
monomer). This SspB2 dimer was then fused to the N-terminus of Rpt2 of the base.
Ubiquitin purification and dimer synthesis
Ubiquitin was expressed and purified as previously described51,52. Briefly, Rosetta II (DE3) 
pLysS Escherichia coli cells were transformed with a pET28a vector containing the 
ubiquitin gene from S. cerevisiae under control of a T7 promoter. Cells were grown in 
Terrific Broth supplemented with 1% glycerol at 37 °C until OD600 = 1.5–2.0 and were 
induced with 0.5 mM IPTG overnight at 18 °C. The lysis buffer contained 50 mM Tris-HCl, 
pH 7.6, 0.02% NP-40, 2 mg mL−1 lysozyme, benzonase (Novagen), and protease inhibitors 
(aprotinin, pepstatin, leupeptin and PMSF). Cells were lysed by sonication and 20 min 
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incubation at room temperature. Lysate was clarified by centrifugation at 15000 rpm. 
Clarified lysate was precipitated by adding 60% perchloric acid to a final concentration of 
0.5%, and the solution was stirred on ice for a total of 20 min. A 5-mL HiTrap SP FF 
column (GE Life Sciences) was used for cation-exchange chromatography, and ubiquitin 
fractions were pooled and exchanged into Ub storage buffer (20 mM Tris-HCl, pH 7.6, and 
150 mM NaCl) by repeated dilution and concentration.
Lys-48 ubiquitin dimers were synthesized and purified as previously described34.
Preparation of Ubiquitin fused Ubp6
50 µM WT Ubp6 or Δubl Ubp6 protein was reacted with 75 µM ubiquitin vinyl sulfone or 
ubiquitin aldehyde (R&D Systems) in GF buffer at 37 °C. For the experiment in Figure 5d, 
which required complete inhibition of the active site cysteine, buffer, wild-type Ubp6, or 
C118A Ubp6 were reacted with ubiquitin aldehyde for seven hours at 37°C in the dark. To 
ensure complete inactivation, Ubp6-UbH was further reacted with 500 µM NEM for 30 min 
at 30 °C, followed by quenching with 5 mM DTT for another 30 min at 30 °C. Ubiquitin-
aldehyde, NEM, and DTT were removed by dilution and concentration in an Amicon 30K 
MCWCO concentrator (EMD Milipore).
Ubiquitin AMC hydrolysis assays
Ubiquitin-AMC (R&D systems) hydrolysis was measured in a QuantaMaster 
spectrofluorimeter (PTI) by monitoring an increase of fluorescence emission at 435 nm with 
an excitation at 380 nm. Reactions using reconstituted proteasome used 100 nM Ubp6, 150 
nM Rpn1, 150 nM recombinant base, 300 nM CP, 300 nM Lid, 300 nM Rpn10, 20 µM 
unfolded substrate, and 3–10 µM Ub-AMC. Reactions using proteasomes purified from 
yeast used 100 nM proteasome. Reactions were carried out either in the presence GF buffer 
(see above) with 1mM DTT and 1× ATP regeneration system or 1 mM ATPgS. Samples 
were incubated at 30 °C for 5–10 minutes prior to the addition of substrate to ensure Ubp6 
association and nucleotide exchange.
ATPase assays
ATPase activity was quantified by an NADH-coupled ATPase assay. Reconstituted 
proteasomes, (200 nM base, 600 nM core, 600 nM lid, 600nM Rpn10) Ubp6, (200 nM) 
Ub2K48 (20 µM), and unfolded gene-3-protein substrate (20 µM) were incubated with 1× 
ATPase mix (3 U ml−1 pyruvate kinase, 3 U ml−1 lactate dehydrogenase, 1 mM NADH and 
7.5 mM phosphoenol pyruvate) at 30 °C. Reactions were done in GF buffer (see above) with 
1mM DTT. Absorbance at 340 nm was monitored at 30 °C for 600 s at 1-s intervals by a 
UV-vis spectrophotometer (Agilent).
Multiple and Single turnover ubiquitin independent degradation assays
26S proteasomes were reconstituted using recombinant, heterologously-expressed SspB2-
Rpt2 base, recombinant Rpn10, and lid and core subcomplexes purified from yeast. Multiple 
turnover degradations were done with 200 nM CP, 600nM Lid, 600 nM base, 600 nM 
Rpn10, 900 nM Ubp6 and 20 µM Ub2K48. Reactions were done in the presence of 1× ATP 
regeneration system (5 mM ATP, 0.03 mg ml−1 creatine kinase, 16 mM creatine phosphate) 
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in gel filtration buffer with 1mM DTT. Single turnover reactions were done with 3 µM 
SspB2-Rpt2 base, 4.5 µM lid, 4.5 µM base, 4.5 µM Rpn10, 9 µM Ubp6, 20 µM Ub2K48, and 
300 nM substrate in the presence of 1× ATP regeneration system in gel filtration buffer with 
DTT and ATP regeneration system. GFP single- and multiple-turnover degradation activities 
were monitored by the loss of GFP fluorescence (excitation, 467 nm; emission, 511 nm) 
using a QuantaMaster spectrofluorimeter (PTI). Single turnover curves were fit to a single 
exponential in GraphPad Prism 6.
To track degradation of an unfolded substrate, purified N1 fusion substrates were labeled on 
a single cysteine with Alexa 647 maleimide at pH 7.2 for 3 hours at room temperature in the 
dark, before quenching unreacted dye with DTT. Free dye was removed on a Superdex 200. 
Substrate degradation was measured by taking time-points of a reaction at 30 °C and 
assessed by SDS-PAGE followed by imaging on a Typhoon Trio (GE) with a 633 nm laser 
and 670 nm BP emission filter. Band intensity was quantified using Image Quant software. 
Degradation reactions consisted of 8 µM substrate against proteasomes reconstituted as 
above with either SspB2-Rpt2 base or WT base to correct for any non-specific, SspB2 
independent substrate cleavage.
Preparation of Ubiquitinated substrates
GFP substrates (20 µM) were modified with polyubiquitin chains by 5 µM yeast Uba1, 5 µM 
yeast Ubc1, 5 µM Rsp5, 1× ATP Regeneration system, and 300 µM ubiquitin. Reaction was 
carried out in a thermocycler for 2 hours at 25 °C, then overnight at 4 °C.
Multiple and Single turnover ubiquitin dependent degradation assays
GFP constructs were ubiquitinated overnight and then used the next day without freezing. 
Single- and multiple-turnover degradation activities were monitored by the loss of GFP 
fluorescence (excitation, 467 nm; emission, 511 nm) using a QuantaMaster 
spectrofluorimeter (PTI) as above. Multiple turnover reactions consisted of 300 nM purified 
proteasomes from a ΔUbp6 strain, 600nM Ubp6, and 2µM substrate. Single-turnover 
reactions consisted of 3 µM proteasome, 6 µM Ubp6, and 300 nM substrate.
For the gel-based assessment of substrate degradation and deubiquitination, 2 µM 
ubiquitinated EGFP substrate was incubated with 200 nM ΔUbp6 proteasomes in the 
presence of buffer or 400 nM WT, C118A or UbVS-treated Ubp6. Aliquots at different time 
points were separated on a SDS-PAGE gel, and the gel was imaged on a Typhoon Trio (GE) 
with excitation at 488 nM and using a 526 nm SP emission filter.
Electron microscopy
Samples of 26S-bound Ubp6-UbVS were diluted to ~25 nM in 60 mM HEPES pH 7.6, 50 
mM NaCl, 50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 1 mM TCEP and either 1 mM ATP 
or 1 mM ATPgS (Sigma). A thin layer of carbon was applied to 400-mesh Cu-Rh 
maxtaform grids (Electron Microscopy Sciences) by chemical vapor deposition, and grids 
were subsequently exposed to a 95% Ar/5% O2 plasma for 20 seconds to glow-discharge/
activate the carbon surface. Grids were pre-treated with 4 µl of 0.1% poly-L-lysine 
hydrobromide (Polysciences) to prevent preferred orientation of 26S particles on carbon. 
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Poly-L-lysine solution was then wicked away, grids were washed with 4 µl of H2O, and 4 µl 
of sample was applied. 252 and 357 images of negatively stained (2% uranyl formate) 26S-
Ubp6-UbVS complexes in the presence of ATP or ATPgS, respectively, were collected at a 
nominal magnification of 52,000 × on an F416 CMOS 4K × 4K camera (TVIPS) with a 
pixel size of 2.05 Å/pixel at the sample level. Images were acquired on a Tecnai Spirit LaB6 
electron microscope operating at 120keV, with a random defocus range of −0.5 µm to −1.5 
µm and an electron dose of 20e-/Å2. Data were acquired using the Leginon automated image 
acquisition software53.
Processing
All image preprocessing and 2D analysis was performed using the Appion image-processing 
pipeline47. CTF was estimated using CTFFIND3, and only micrographs having a CTF 
confidence greater than 80% were used for processing. Particle picking was performed using 
the template-based FindEM software54. Micrographs were phaseflipped using EMAN’s 
“applyctf” function, and particles were extracted with a box size of 384 pixels. Pixel values 
4.5 sigma above or below the mean were replaced with the mean intensity of the extracted 
particle using XMIPP. Multiple rounds of iterative MSA/MRA was used for 2D 
classification and alignment of the particles, and class averages containing single-capped 
proteasomes, as well as damaged, aggregated, or false particles, were removed, resulting in a 
dataset containing 24,411 and 18,565 double-capped proteasome particles in presence of 
1mM ATP and 1mM ATPgS, respectively. 3D classification and 3D refinement were 
performed with C2 symmetry imposed using RELION v1.3155. The 3D reoconstructions for 
proteasomes in the presence of ATP and ATPgS resolved to 24.2 Å and 22.3 Å, 
respectively, according to a gold standard Fourier Shell Correlation at 0.143. Low resolution 
intensities were dampened using a SPIDER script in order to more clearly visualize domain 
features.
3D modeling
An atomic model of yeast Ub-bound Ubp6 was constructed by superimposing the yeast 
Ubp6 crystal structure (PDB 1VJV) onto the stucture of the human Rsp14 structure bound to 
Ubiquitin (PDB 2AYO)23, using UCSF Chimera’s “MatchMaker” tool. These structures 
have high structural homology, and the resulting hybrid structure did not exhibit any clashes 
between the Ubiquitin and Ubp6. This Ubp6-Ub model was docked into the density 
putatively corresponding to Ubp6. PDB 4CR445 was used for docking other 26S core, base 
and lid subunits into the ATPγS electron density map obtained here, with the exception of 
the Rpn8-Rpn11 dimer, for which PDB 4O8Y46 was used. All docking of PDB structures 
was performed using the “Fit in Map” tool of UCSF Chimera, and this software was also 
used to generate all figures displaying the EM density56.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ubp6 deubiquitination activity responds to the conformational state of the proteasome
Ub-AMC cleavage activity of Ubp6 was measured in response to interactions with the 
proteasomes holoenzyme or isolated subcomplexes. (a) Deubiquitination assays using 
proteasomes reconstituted with heterologously expressed base subcomplex purified from E. 
coli as well as core and lid subcomplexes purified from yeast, in the presence of ATP or the 
non-hydrolyzable ATPγS that induces the engaged state of the proteasome. (b) 
Deubiquitination assays using proteasomes purified from yeast strains with either wild-type, 
deleted, or inactive (C118A) Ubp6, or with wild-type Ubp6 and an inactive Rpn11 (AXA). 
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Shown are the relative activities in the presence of ATPγS compared to ATP. Data in a and 
b are means and s.e.m.of three independent experiments.
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Figure 2. Ubp6 allostery is connected to substrate engagement
To separate ubiquitin processing from substrate engagement and translocation, we designed 
an ubiquitin-independent recruitment system by fusing a linked permutant of the bacterial 
dimeric substrate adapter SspB2 to Rpt2 of the base. (a) Schematic of a SspB2-fused 
proteasome recruiting an ssrA tagged substrate and SDS-PAGE of E. coli-expressed base 
subcomplex with either wild-type or SspB2-fused Rpt2. (b) Degradation of a GFP model 
substrate containing the ssrA recognition motif was measured using proteasomes 
reconstituted with either wild-type or SspB2-fused base complexes. (c) Ubiquitin-bound 
Ubp6 (Ubp6 C118A with di-ubiquitin or ubiquitin-vinylsulfone-fused Ubp6, Ubp6-UbVS) 
and substrate translocation stimulate the ATPase rate of SspB2-fused proteasomes. Data 
shown in b and c are means and s.e.m. of three technical replicates.
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Figure 3. Ubiquitin-bound Ubp6 interacts with the Rpt hexamer of the base
(a) 3D reconstructions of the proteasome holoenzyme in complex with ATPγS and 
ubiquitin-free (left) or permanently ubiquitin-bound Ubp6 shown in red (right). (b–e) PDB 
models of various RP subunits were docked into the 3D electron density map obtained from 
negatively stained samples. Rpn1 is shown in purple (PDB 4CR4 Chain Z)45, Rpn11 in 
green (PDB 4O8X)46, and the ATPase ring in blue (PDB 4CR4, Chains H-M). The Ubp6-
Ub homology model was docked into the corresponding density of the 22.3-Å resolution 
map (Ubp6 is shown in red, ubiquitin in blue). PDB models for all Rpt proteins of the base 
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are alternately colored in two different shades of blue. (b) Front view of the RP. Connecting 
density is observed between Rpn1 and the catalytic domain of Ubp6, which contacts the Rpt 
ring directly in front of Rpn11. (c) Top view of the RP. Ubp6 makes specific contacts with 
the N-terminal domain of Rpt1. (d) Side view of the RP. Ubp6 bridges the N-ring and the 
AAA+ ring in their coaxially stacked, engaged conformation. The N-domain residues of 
Rpt1 appear to interact with surface loops of Ubp6, while the AAA+ domain of Rpt1 
contacts two C-terminal helices of Ubp6. This architecture places Ubp6 in close proximity 
to Rpn11 (~20 Å), with its bound ubiquitin only ~30 Å from the Rpn11 active site. (e) 
Zoomed-in view of (d), highlighting the Ubp6-base interface and proximity to Rpn11.
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Figure 4. Ubiquitin-bound Ubp6 stabilizes the substrate-engaged conformation of the 
proteasome
Ubiquitin-independent substrate delivery to the proteasome reveals that ubiquitin-bound 
Ubp6 allosterically inhibits multiple- but not single-turnover degradation. (a) Multiple-
turnover degradation of a permanently unfolded model substrate and a GFP fusion substrate 
by reconstituted SspB2-Rpt2 proteasomes in the absence or presence of Ubp6 C118A and di-
ubiquitin (Ub2). Data shown are means and s.e.m of three technical replicates. 
Representative gels are shown in Supplementary Data Set 1. (b) Single-turnover degradation 
of the GFP fusion substrate by saturating amounts of reconstituted SspB2-Rpt2 proteasomes 
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in the absence or presence of Ubp6 C118A and Ub2. Curves shown are representative of 
three individual experiments. (c) Rate constants for degradation of the GFP fusion substrate 
under multiple- and single-turnover conditions shown in (a) and (b). Rate constants for 
single turnover degradations were determined from a single exponential regression of data; 
error bars represent s.e.m. of three individual experiments.
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Figure 5. Ubp6 affects ubiquitin-dependent degradation
(a) Ubiquitin binding to Ubp6 strongly inhibits Rpn11 deubiquitination activity. Ubp6 (wild 
type or C118A) was treated with ubiquitin aldehyde (Ub-H) and added to Ubp6-free 
holoenzymes purified from yeast. Rpn11 deubiquitination activity was measured by Ub-
AMC cleavage. Data are means and s.e.m. of 3 independent experiments. (b,c) The same 
GFP fusion substrate used for ubiquitin-independent turnover in figure 4 was ubiquitinated 
in vitro at an engineered single lysine residue, to examine the effects of Ubp6 on ubiquitin-
dependent substrate degradation. (b) Single-turnover degradation of the polyubiquitinated 
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GFP fusion substrate were measured with saturating amounts of proteasome holoenzyme 
purified from an Ubp6-knockout yeast strain, with no Ubp6, wild-type Ubp6, Ubp6 C118A, 
or Ubp6-UbVS added back. (c) Rate constants for single- and multiple-turnover degradation 
of the ubiquitinated GFP model substrate. Data shown are means and s.e.m. from three 
technical replicates. (d) Degradation of a poly-ubiquitinated EGFP20,47 substrate was 
assessed by SDS-PAGE and in-gel GFP fluorescence detection. Used proteasomes were 
purified from ubp6Δ yeast cells and incubated with either buffer, WT, C118A or UbVS-
treated Ubp6.
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Figure 6. Model for Ubp6 acting as an ubiquitin-dependent timer to allosterically control 
proteasome conformational changes, Rpn11 deubiquitination, and substrate degradation
(a) Ubiquitin-chain binding to an intrinsic receptor (e.g. Rpn10) tethers a substrate to the 
proteasome. Ubp6 is bound to the proteasome via its Ubl domain interacting with Rpn1. (b) 
Engagement of the unstructured initiation region of the substrate by the ATPase hexamer 
induces a conformational switch of the regulatory particle to a substrate-engaged, 
translocation competent state, characterized by a coaxial alignment of Rpn11, N-ring, AAA
+ ring and 20S core. If ubiquitin-bound, for instance during debranching or trimming of 
ubiquitin chains, Ubp6 interacts with and stabilizes the engaged state of the ATPase 
hexamer by bridging the N-ring and AAA+ ring. In this state, ubiquitin-bound Ubp6 inhibits 
Rpn11-mediated deubiquitination and consequently substrate degradation. (c) Translocation 
moves the ubiquitin-modified lysines of the substrate into the Rpn11 active site for co-
translocational ubiquitin-chain removal. (d) Even after complete substrate translocation, 
ubiquitin-bound Ubp6 stabilizes the engaged conformation of the proteasome, prevents 
switching back to the engagement-competent state, and thus interferes with the degradation 
of the subsequent substrate. Such trapping of the engaged state would allow Ubp6 to clear 
ubiquitin chains from proteasomal receptors before the next substrate is engaged and 
degradation is initiated. (e) As soon as it is no longer occupied with ubiquitin, the catalytic 
domain of Ubp6 releases from the N-ring and AAA+ ring, and allows the regulatory particle 
to return to the pre-engaged state for the next round of substrate degradation.
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